CSL Behring
HAEGARDA
Manufacturer:
CSL Behring
Name:
HAEGARDA
HCPCS Code Descriptor:
Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
Category:
J Code
HCPCS:
J0599
NDC(s):
63833-0829-02, 63833-0828-02
Primary Type:
Immunology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
HAEGARDA is an Immunology drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J0599 is aligned to the drug HAEGARDA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/22
HCPCS Short Description:
Inj., haegarda 10 units
Billing and Coding Guide:
https://labeling.cslbehring.com/PRODUCT-DOCUMENT/US/HAEGARDA/EN/HAEGARDA-Code-Reimbursement-Guide.pdf
Patient Assistance:
https://www.cslbehring.com/patients/support-and-assistance